Interleukin-18(IL-18) and Atherosclerosis

被引:0
|
作者
Givtaj, Nozar [1 ]
Bassiri, Hossein Ali [1 ]
Givtaj, Nader [1 ]
Simin, Asghar [1 ]
Noohi, Feridoun [1 ]
机构
[1] Univ Tehran Med Sci, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran
来源
IRANIAN HEART JOURNAL | 2012年 / 13卷 / 01期
关键词
Inflammation; Atherosclerosis; Interleukin; 18; CAD; Cytokine;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background- Atherosclerosis is a dynamic and progressive disease arising from the combination of endothelial dysfunction and inflammation. So, inflammatory mediators are important causative and progressive factors in atherosclerosis. Interleukin-18 (IL-18) is a pleiotropic cytokine which may have a key role in atherosclerosis, because the results of recent studies indicated that IL-18, either directly as a pro-inflammatory factor or indirectly as an interferon inducing factor, has central role in the inflammatory cascade. In present study, we evaluated the relation between blood concentration of IL-18 with atherosclerosis and its severity and also the relation of this cytokine with the other known risk factors of coronary artery disease (CAD). Methods- 138 patients who underwent diagnostic cardiac catheterization and had the inclusion criteria for this study, were selected. In the beginning, a questionnaire containing personal information and medical history was completed for each of them and blood samples were collected 24 hours before catheterization. We measured blood level of IL-18 and CRP in all samples. The results of these tests and the angiography were entered in the questionnaire and then information was analyzed using regression analyzing, K2 and statistical T test. P values of <0.05 were considered statistically significant. Results- By using the results of angiography, patients were divided in two groups. 1-Control group or normal coronary arteries (32 people) 2- Case group (106 people) or patients who were suffering from CAD. In second group, 6 patients (5.6%) had minimal CAD, 44 patients (41.5%) had single-vessel disease (SVD), 27 patients (25.4%) had 2VD and 29 patients (27.5%) had 3VD. In the laboratory tests, the mean IL-18 blood level in patients with CAD was 258.1 pgr/ml but in normal coronary arteries group it was 216.6 pgr/ml. The average blood level of IL-18 in patients who had minimal CAD was 235.5 pgr/ml, in SVD was 247.2 pgr/ml, in 2VD was 263.7 pgr/ml and in patients with 3VD was 274.1 pgr/ml. Also average CRP blood level in normal group was 8.9 mgr/L while in patients with CAD it was 20.4 mgr/L. Conclusion- The results of this study indicated that there was a direct and significant correlation between blood IL-18 level with existence (P<0.001) and severity of CAD (P<0.01) and IL-18 can be an independent predictor risk factor of atherosclerosis.
引用
收藏
页码:11 / 16
页数:6
相关论文
共 50 条
  • [1] Interleukin-18 and IL-18 binding protein
    Dinarello, Charles A.
    Novick, Daniela
    Kim, Soohyun
    Kaplanski, Gilles
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [2] Targeting Interleukin-18 (IL-18) in malaria infection
    Basir, R.
    Hasballah, K.
    Ismail, S.
    Gam, L. H.
    Mahmud, R.
    Majid, A. M. S. Abdul
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2009, 14 : 125 - 126
  • [3] Interleukin-18 (IL-18), a marker for bacterial pneumonia?
    Peleman, RA
    Fleurinck, C
    Van de Velde, V
    Kips, JC
    Pauwels, RA
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A751 - A751
  • [4] Interleukin-18 (IL-18) in rheumatoid arthritis (RA)
    Gracie, JA
    Forsey, RJ
    Gilmour, A
    Chan, L
    Field, M
    Liew, FY
    Sturrock, RD
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S297 - S297
  • [5] Bioactivity and secretion of interleukin-18 (IL-18) generated by equine and feline IL-18 expression constructs
    O'Donovan, LH
    McMonagle, EL
    Taylor, S
    Argyle, DJ
    Nicolson, L
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2004, 102 (04) : 421 - 428
  • [6] Interleukin-18, Functional IL-18 Receptor and IL-18 Binding Protein Expression in Active and Latent Tuberculosis
    Wawrocki, Sebastian
    Kielnierowski, Grzegorz
    Rudnicka, Wieslawa
    Seweryn, Michal
    Druszczynska, Magdalena
    PATHOGENS, 2020, 9 (06): : 1 - 11
  • [7] Interleukin-18 (IL-18) and IL-18 binding protein (IL-18BP) in patients with juvenile idiopathic arthritis.
    De Benedetti, F
    Meazza, C
    Martini, A
    Novick, D
    Rubinstein, M
    Dinarello, CA
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S473 - S473
  • [8] Interleukin-18 (IL-18): a novel urinary biomarker for the diagnosis of preeclampsia
    Luo, Guoyang
    Parikh, Chirag
    Park, Joong Shin
    Kim, Byoung Jae
    Tadese, Serkalem
    Snegovskikh, Victoria
    Zheng, Ting
    Bahtiyar, Mert
    Norwitz, Errol
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (06) : S283 - S284
  • [9] Interleukin-18 (IL-18) is required for the induction of autoimmune diabetes in mice
    Lukic, ML
    Mensah-Brown, E
    Shahin, A
    Liew, FY
    FASEB JOURNAL, 2004, 18 (05): : A1167 - A1167
  • [10] Interleukin-18 (IL-18) is increased in SLE and induced by TNF.
    Aringer, M
    Steiner, G
    Ekhart, H
    Hoefler, E
    Meyer, B
    Smolen, JS
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S201 - S201